Rilonacept Completed Phase 3 Trials for Genetic Diseases, Inborn / Muckle-Wells Syndrome (MWS) / Familial Cold Autoinflammatory Syndrome (FCAS) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00288704Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)